je.st
news
Tag: zacks
Zacks Investment Research Downgrades Cal-Maine Foods Inc (CALM) to Hold
2015-12-29 07:29:08| Food - Topix.net
According to Zacks, "Cal-Maine Foods, Inc. is engaged in the production, cleaning, grading, and packaging of fresh shell eggs for sale to shell egg retailers. The company is the one of the largest producers and distributors of fresh shell eggs in the United States.
Tags: research
hold
investment
foods
Zacks Investment Research Downgrades Cal-Maine Foods Inc (CALM) to Hold
2015-12-29 06:52:34| Livestock - Topix.net
According to Zacks, "Cal-Maine Foods, Inc. is engaged in the production, cleaning, grading, and packaging of fresh shell eggs for sale to shell egg retailers. The company is the one of the largest producers and distributors of fresh shell eggs in the United States.
Tags: research
hold
investment
foods
Papa Murphy's Holdings Inc (FRSH) Upgraded to "Hold" by Zacks Investment Research
2015-12-29 06:15:25| Grocery - Topix.net
According to Zacks, "Papa Murphy's Holdings Inc. operates as a franchisor and operator of the Take 'N' Bake pizza chain in the United States. The Company operates in three segments: Domestic Company Stores, Domestic Franchise and International.
Tags: research
hold
investment
holdings
Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell
2015-12-29 06:13:10| Biotech - Topix.net
According to Zacks, "Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals.
Tags: research
sell
investment
discovery
CTI BioPharma Corp (CTIC) Upgraded at Zacks Investment Research
2015-12-29 06:13:09| Biotech - Topix.net
The brokerage currently has a $1.50 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target would indicate a potential upside of 16.28% from the stock's current price.
Tags: research
investment
corp
upgraded
Sites : [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] next »